1980
DOI: 10.1254/jjp.30.1
|View full text |Cite
|
Sign up to set email alerts
|

DIFFERENTIAL EFFECTS OF Α-Methyldopa, CLONIDINE AND HYDRALAZINE ON NOREPINEPHRINE AND EPINEPHRINE SYNTHESIZING ENZYMES IN THE BRAINSTEM NUCLEI OF SPONTANEOUSLY HYPERTENSIVE RATS

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0

Year Published

1982
1982
2019
2019

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 30 publications
1
3
0
Order By: Relevance
“…Consistent with the idea that catecholamine synthesis in the central nervous system and in the periphery is differently regulated and in agreement with previous reports [26–28], we also show that the activity of tyrosine hydroxylase and catecholamine levels in the brain of spontaneously hypertensive rats was reduced after clonidine treatment. Catecholamine synthesis in spontaneously hypertensive rat brain has been shown to be decreased in the pre‐hypertensive stage and increased in hypertensive animals [29].…”
Section: Discussionsupporting
confidence: 94%
“…Consistent with the idea that catecholamine synthesis in the central nervous system and in the periphery is differently regulated and in agreement with previous reports [26–28], we also show that the activity of tyrosine hydroxylase and catecholamine levels in the brain of spontaneously hypertensive rats was reduced after clonidine treatment. Catecholamine synthesis in spontaneously hypertensive rat brain has been shown to be decreased in the pre‐hypertensive stage and increased in hypertensive animals [29].…”
Section: Discussionsupporting
confidence: 94%
“…Co-exposure of cells with the CYP1A inhibitor α-naphthoflavone did not result in reduced bioactivity of 3- and 8-methylquinoline (Figure , +ANF). However, their effects were significantly suppressed in the presence of hydralazine, which is a known inhibitor of AOX and several NMTs. The effect of 3-methylquinoline was reduced by 55% (one-way ANOVA with Dunnett’s multiple comparison test, p = 0.0013) and that of 8-methylquinoline by 23% ( p = 0.0324). On the basis of these findings, it is likely that the transformation of methylquinolines to bioactive metabolites was catalyzed by either AOXs or NMTs.…”
Section: Resultsmentioning
confidence: 99%
“…An E2 (Sigma-Aldrich) dilution series ranging from 0.1 to 100 pM and a DMSO solvent control (0.1%) were included in triplicates on each plate. In addition to testing of individual chemicals, cells were coexposed to 150 mg L –1 3-methylquinoline and 8-methylquinoline, respectively, and either the AOX/NMT inhibitor hydralazine, or the CYP1A inhibitor α-naphthoflavone (both 25 μM). After 24 h exposure (37 °C, 5% CO 2 ), the cells were lysed with 30 μL of lysis reagent.…”
Section: Materials and Methodsmentioning
confidence: 99%
“…Despite the large body of clinical experience, and its long use as an antihypertensive, its mechanism of action has been reconsidered several times since the recognition of its antihypertensive effect (17). Earlier works suggested a peripheral site of action, involving either the inhibition of transmitter synthesis or the metabolism to α‐methylnoradrenaline, which acts as a ‘false’ transmitter, thereby decreasing the sympathetic activity (7), (8), (18). It was later proved that α‐methyldopa acts centrally, though peripheral effects were not excluded (19).…”
Section: Discussionmentioning
confidence: 99%